FinscoFinsco

Evolent Health (US.EVH)

Capital Allocation Audit · Period: 2013 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.EVH · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion228.7%↑
ROE-14.4%→
Cash Conversion-→
D/E Ratio2.53↓
Gross Margin14.3%↓
US.EVH (Evolent Health) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion   228.7%    ↑
ROE              -14.4%    →
Cash Conversion       -    →
D/E Ratio          2.53    ↓
Gross Margin      14.3%    ↓
Key Metrics
US.EVH (Evolent Health) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 228.7% ↑
ROE -14.4% →
Cash Conversion - →
D/E Ratio 2.53 ↓
Gross Margin 14.3% ↓

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-CAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesMicron TechnologySanDiskSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies